Oakmont Advisory Group, LLC

Position in VKTX — Viking Therapeutics, Inc.

CIK 2115370 ALBUQUERQUE, NM

Position in VKTX

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$7

New position

Shares Held

0

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#431

of 432 holders

Holding Since

Jun 2026

1 quarter on record

Healthcare · as of Jun 30, 2026

Oakmont Advisory Group, LLC holds $853,774 across 5 Biotechnology names. VKTX ranks #5 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	7,583	$412,591
2	HALO	Halozyme Therapeutics, Inc.	4,953	$387,671
3	INCY	Incyte Corp	461	$52,258
4	REGN	Regeneron Pharmaceuticals, Inc.	2	$1,247
5	VKTX	Viking Therapeutics, Inc. This page	0	$7

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7	0	—	Shares	Sole	2026-08-03
No filing history on record for this holder in this stock.